Showing results (891-900 of 2,061) with videos related to
Sort By:
Pageof 207
Brachytherapy|June 26, 2012
Analysis of fat necrosis after adjuvant high-dose-rate interstitial brachytherapy for early stage breast cancerAdam A Garsa, Daniel J Ferraro, Todd Dewees, et al.Brachytherapy|June 27, 2012
Optimization and comparison of balloon-based partial breast brachytherapy using a single source, a standard plan line source, and both forward and inverse planned multilumen techniquesKatie Eyre, Diane Whitney, Mukesh Mukesh, et al.Brachytherapy|July 4, 2012
Permanent seed brachytherapy for locally recurrent prostate cancer after radical prostatectomy: a case report and review of the literatureMiren Gaztañaga, Juanita Mary CrookBrachytherapy|March 5, 2015
High-dose-rate brachytherapy as a monotherapy for prostate cancer--Single-institution results of the extreme fractionation regimenAndrzej Marek Kukiełka, Tomasz Dąbrowski, Tomasz Walasek, et al.Brachytherapy|April 12, 2015
Perioperative high-dose-rate interstitial brachytherapy combined with external beam radiation therapy for soft tissue sarcomaDaya Nand Sharma, S V Suryanarayana Deo, Goura Kisor Rath, et al.Brachytherapy|June 11, 2014
Investigation of interseed attenuation and tissue composition effects in (125)I seed implant prostate brachytherapyJosh Mason, Bashar Al-Qaisieh, Peter Bownes, et al.Brachytherapy|April 17, 2021
Radioactive and normal stent insertion for the treatment of malignant airway stenosis: A meta-analysisQing-Kun Meng, Xiao-Ying Yu, Wei Li, et al.Brachytherapy|April 19, 2021
Patient-controlled epidural analgesia, patient-controlled intravenous analgesia, and conventional intravenous opioids for gynecologic interstitial brachytherapy: A single-center retrospective studyYuya Murata, Kumiko Yamada, Yuto Hamaguchi, et al.Brachytherapy|September 25, 2012
Microbrachytherapy using holmium-166 acetylacetonate microspheres: a pilot study in a spontaneous cancer animal modelWouter Bult, Maarten A D Vente, Eva Vandermeulen, et al.Brachytherapy|March 3, 2015
Salvage low-dose-rate permanent seed brachytherapy for locally recurrent prostate cancer: Association between dose and late toxicityJim N Rose, Juanita M Crook, Tom Pickles, et al.Pageof 207